# U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod

> **NCT00606034** · PHASE4 · COMPLETED · sponsor: **Mountain Diabetes and Endocrine Center** · enrollment: 21 (actual)

## Conditions studied

- Type 2 Diabetes
- Insulin Resistance

## Interventions

- **DRUG:** U-500 Insulin delivered by Omnipod (disposable insulin pump)

## Key facts

- **NCT ID:** NCT00606034
- **Lead sponsor:** Mountain Diabetes and Endocrine Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606034, "U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00606034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*